HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
hat score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–0
  • Low-Moderate Risk1–1
  • Moderate Risk2–2
  • High Risk3–3
Direct Clinical Answer

The HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage calculates predicting hemorrhage risk after tPA administration in acute ischemic stroke patients. Key inputs include diabetes or glucose. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Predicts hemorrhage risk after tPA administration in acute ischemic stroke patients. Helps determine risk/benefit of tPA in borderline cases and identify patients needing closest monitoring.

Clinical Indication

The HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage is indicated for bedside clinical practice to support Predicts hemorrhage risk after tPA administration in acute ischemic stroke patients. Helps determine risk/benefit of tPA in borderline cases and identify patients needing closest monitoring.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.

Formula & Variables:

HAT Score = Diabetes/Glucose (0-1) + NIHSS Score (0-2) + CT Hypodensity (0-2)

Input Parameters

NameTypeRequiredDescription
diabetes_or_glucosestringYesHistory of diabetes mellitus OR initial blood glucose >200 mg/dL (>11.1 mmol/L)
nihss_scorestringYesPre-tPA NIH Stroke Scale score
hypodensity_on_ctstringYesEasily visible hypodensity on initial head CT

Score Interpretation & Guidance

RangeStageDescription
0–0Low RiskLow hemorrhage risk
1–1Low-Moderate RiskLow-moderate hemorrhage risk
2–2Moderate RiskModerate hemorrhage risk
3–3High RiskHigh hemorrhage risk
4–5Very High RiskVery high hemorrhage risk

Evidence-Based References (EBM)

  • Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008 Oct 28;71(18):1417-23. doi: 10.1212/01.wnl.0000330297.58334.dd.DOI: 10.1212/01.wnl.0000330297.58334.dd
  • Tsivgoulis G, Frey JL, Flaster M, Sharma VK, Lao AY, Hoover SL, et al. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage. Stroke. 2009 Nov;40(11):3631-4. doi: 10.1161/STROKEAHA.109.564096.DOI: 10.1161/STROKEAHA.109.564096
  • Cucchiara B, Kasner SE, Tanne D, Levine SR, Demchuk A, Messe SR, et al. Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage. Int J Stroke. 2011 Apr;6(2):109-11. doi: 10.1111/j.1747-4949.2010.00555.x.DOI: 10.1111/j.1747-4949.2010.00555.x

Related calculators